For citations:
Zeynalova P.A., Timofeeva O.L., Ryabukhina Yu.E., Abbasbeyli F.M., Kupryshina N.A., Zhukov A.G., Valiev T.T. Use of daratumumab drug formulation for subcutaneous administration in multiple myeloma therapy: Literature review and clinical observation. MD-Onco. 2023;3(4):16-27. (In Russ.) https://doi.org/10.17650/2782-3202-2023-3-4-16-27
Email this article 